Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Best Stocks Under $2 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Ur Energy stock logo

1. Ur Energy NYSEAMERICAN:URG

$1.42 +0.09 (+6.77%)
As of 04:10 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$528.52 million
Consensus Rating
Buy
Consensus Price Target
$2.32 (+63.1% Upside)
Volume
10.56 million shares
Average Volume
5.94 million shares
Today's Range
$1.35
▼
$1.43
iBio stock logo

2. iBio NASDAQ:IBIO

$1.43 -0.04 (-2.72%)
As of 04:00 PM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$73.03 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+249.7% Upside)
Volume
754,676 shares
Average Volume
801,651 shares
Today's Range
$1.42
▼
$1.50
Inuvo stock logo

3. Inuvo NYSEAMERICAN:INUV

$0.73 +0.01 (+0.79%)
As of 04:10 PM Eastern

Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). More about Inuvo

Market Capitalization
$11.87 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+589.0% Upside)
Volume
189,697 shares
Average Volume
305,094 shares
Today's Range
$0.71
▼
$0.76
Stereotaxis stock logo

4. Stereotaxis NYSEAMERICAN:STXS

$1.42 -0.02 (-1.39%)
As of 04:10 PM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization
$144.29 million
Consensus Rating
Buy
Consensus Price Target
$3.70 (+160.6% Upside)
Volume
357,867 shares
Average Volume
804,208 shares
Today's Range
$1.40
▼
$1.47
Nouveau Monde Graphite stock logo

5. Nouveau Monde Graphite NYSE:NMG

$1.50 +0.12 (+8.33%)
As of 03:58 PM Eastern

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization
$221.94 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.67 (+212.2% Upside)
Volume
614,026 shares
Average Volume
371,778 shares
Today's Range
$1.40
▼
$1.51
Tenaya Therapeutics stock logo

6. Tenaya Therapeutics NASDAQ:TNYA

$0.70 +0.01 (+0.98%)
As of 04:00 PM Eastern

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization
$154.83 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.00 (+473.6% Upside)
Volume
1.12 million shares
Average Volume
2.06 million shares
Today's Range
$0.69
▼
$0.72

7. NervGen Pharma NASDAQ:NGEN

$1.86 +0.10 (+5.68%)
As of 04:00 PM Eastern

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen Pharma

Market Capitalization
$141.91 million
Consensus Rating
Moderate Buy
Consensus Price Target
$14.00 (+652.7% Upside)
Volume
541,468 shares
Average Volume
385,883 shares
Today's Range
$1.73
▼
$1.86
Caribou Biosciences stock logo

8. Caribou Biosciences NASDAQ:CRBU

$1.66 +0.05 (+3.11%)
As of 04:00 PM Eastern

Caribou Biosciences, Inc, a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. More about Caribou Biosciences

Market Capitalization
$172.60 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.75 (+366.9% Upside)
Volume
1.16 million shares
Average Volume
1.07 million shares
Today's Range
$1.62
▼
$1.69
Microbot Medical stock logo

9. Microbot Medical NASDAQ:MBOT

$1.50 +0.01 (+0.67%)
As of 04:00 PM Eastern

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. More about Microbot Medical

Market Capitalization
$100.08 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.38 (+325.0% Upside)
Volume
330,720 shares
Average Volume
768,947 shares
Today's Range
$1.49
▼
$1.53
Tvardi Therapeutics stock logo

10. Tvardi Therapeutics NASDAQ:TVRD

$1.86 +0.03 (+1.64%)
As of 04:00 PM Eastern

Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. More about Tvardi Therapeutics

Market Capitalization
$24.41 million
Consensus Rating
Moderate Buy
Consensus Price Target
$18.00 (+867.7% Upside)
Volume
166,830 shares
Average Volume
348,444 shares
Today's Range
$1.82
▼
$1.93
Inovio Pharmaceuticals stock logo

11. Inovio Pharmaceuticals NASDAQ:INO

$1.18 -0.03 (-2.48%)
As of 04:00 PM Eastern

Inovio Pharmaceuticals, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. More about Inovio Pharmaceuticals

Market Capitalization
$125.11 million
Consensus Rating
Moderate Buy
Consensus Price Target
$3.17 (+168.4% Upside)
Volume
5.00 million shares
Average Volume
6.58 million shares
Today's Range
$1.15
▼
$1.24
Humacyte stock logo

12. Humacyte NASDAQ:HUMA

$0.64 -0.04 (-5.75%)
As of 04:00 PM Eastern

Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. More about Humacyte

Market Capitalization
$183.73 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.11 (+851.0% Upside)
Volume
9.36 million shares
Average Volume
8.28 million shares
Today's Range
$0.63
▼
$0.70
Peraso stock logo

13. Peraso NASDAQ:PRSO

$0.67 +0.02 (+2.95%)
As of 04:00 PM Eastern

Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about Peraso

Market Capitalization
$9.65 million
Consensus Rating
Moderate Buy
Consensus Price Target
$3.08 (+357.5% Upside)
Volume
147,307 shares
Average Volume
332,928 shares
Today's Range
$0.65
▼
$0.68
Canaan stock logo

14. Canaan NASDAQ:CAN

$0.36 +0.08 (+27.29%)
As of 04:00 PM Eastern

Canaan Inc engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. More about Canaan

Market Capitalization
$199.75 million
Consensus Rating
Moderate Buy
Consensus Price Target
$2.01 (+465.7% Upside)
Volume
95.10 million shares
Average Volume
14.29 million shares
Today's Range
$0.29
▼
$0.38
Milestone Pharmaceuticals stock logo

15. Milestone Pharmaceuticals NASDAQ:MIST

$1.06 +0.03 (+2.43%)
As of 04:00 PM Eastern

Milestone Pharmaceuticals Inc, a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. More about Milestone Pharmaceuticals

Market Capitalization
$128.23 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.40 (+506.6% Upside)
Volume
1.90 million shares
Average Volume
1.77 million shares
Today's Range
$1.03
▼
$1.07
Context Therapeutics stock logo

16. Context Therapeutics NASDAQ:CNTX

$0.50 -0.02 (-3.77%)
As of 04:00 PM Eastern

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$47.75 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.17 (+1,133.1% Upside)
Volume
1.74 million shares
Average Volume
2.00 million shares
Today's Range
$0.50
▼
$0.55
Biomea Fusion stock logo

17. Biomea Fusion NASDAQ:BMEA

$1.37 +0.01 (+0.74%)
As of 04:00 PM Eastern

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea Fusion

Market Capitalization
$98.58 million
Consensus Rating
Moderate Buy
Consensus Price Target
$8.20 (+498.5% Upside)
Volume
572,719 shares
Average Volume
521,271 shares
Today's Range
$1.32
▼
$1.38
HeartBeam stock logo

18. HeartBeam NASDAQ:BEAT

$0.49 +0.02 (+3.14%)
As of 04:00 PM Eastern

BioTelemetry, Inc, a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. More about HeartBeam

Market Capitalization
$26.95 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.00 (+710.9% Upside)
Volume
201,536 shares
Average Volume
465,987 shares
Today's Range
$0.47
▼
$0.50
Rani Therapeutics stock logo

19. Rani Therapeutics NASDAQ:RANI

$0.88 +0.03 (+3.41%)
As of 04:00 PM Eastern

Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani Therapeutics

Market Capitalization
$105.42 million
Consensus Rating
Moderate Buy
Consensus Price Target
$8.75 (+894.3% Upside)
Volume
695,125 shares
Average Volume
755,312 shares
Today's Range
$0.86
▼
$0.90
SKYX Platforms stock logo

20. SKYX Platforms NASDAQ:SKYX

$1.15 +0.05 (+4.55%)
As of 04:00 PM Eastern

SKYX Platforms Corp. provides a series of safe-smart platform technologies. The company's first and second-generation technologies enable light fixtures, ceiling fans, and other electrically wired products to be installed and plugged into a ceiling's electrical outlet box. More about SKYX Platforms

Market Capitalization
$148.97 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.67 (+305.8% Upside)
Volume
867,398 shares
Average Volume
872,204 shares
Today's Range
$1.10
▼
$1.16
MediciNova stock logo

21. MediciNova NASDAQ:MNOV

$1.39 +0.02 (+1.46%)
As of 04:00 PM Eastern

MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. More about MediciNova

Market Capitalization
$67.43 million
Consensus Rating
Moderate Buy
Consensus Price Target
$8.33 (+499.5% Upside)
Volume
25,994 shares
Average Volume
33,507 shares
Today's Range
$1.37
▼
$1.40
Annovis Bio stock logo

22. Annovis Bio NYSE:ANVS

$1.81 +0.02 (+1.12%)
As of 03:58 PM Eastern

Annovis Bio, Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. More about Annovis Bio

Market Capitalization
$76.26 million
Consensus Rating
Moderate Buy
Consensus Price Target
$11.67 (+544.6% Upside)
Volume
618,557 shares
Average Volume
602,596 shares
Today's Range
$1.77
▼
$1.84
DeFi Technologies stock logo

23. DeFi Technologies NASDAQ:DEFT

$0.57 +0.06 (+11.65%)
As of 04:00 PM Eastern

DeFi Technologies, Inc engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. More about DeFi Technologies

Market Capitalization
$199.88 million
P/E Ratio
9.58
Consensus Rating
Moderate Buy
Consensus Price Target
$1.44 (+150.0% Upside)
Volume
5.90 million shares
Average Volume
2.08 million shares
Lucid Diagnostics stock logo

24. Lucid Diagnostics NASDAQ:LUCD

$0.96 +0.00 (+0.41%)
As of 04:00 PM Eastern

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$195.20 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.19 (+334.3% Upside)
Volume
415,335 shares
Average Volume
1.08 million shares
Today's Range
$0.94
▼
$0.98
NeuroSense Therapeutics stock logo

25. NeuroSense Therapeutics NASDAQ:NRSN

$0.38 +0.03 (+7.39%)
As of 04:00 PM Eastern

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. More about NeuroSense Therapeutics

Market Capitalization
$13.23 million
Consensus Rating
Moderate Buy
Consensus Price Target
$8.50 (+2,158.8% Upside)
Volume
128,457 shares
Average Volume
471,349 shares
Today's Range
$0.35
▼
$0.39

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas